China Life Science and Technology Innovation Fund
国寿科创基金
elsewhere's corpus does not cover this subject. The only direct mention of China Life Science and Technology Innovation Fund (also referred to as 国寿科创基金 / 国寿科创基金) is a single co-investment record from 2023, where it followed the lead investors in Inming Biotech's 700 million RMB Series A round alongside Taiping Healthcare Fund and others . No founding date, size, strategy, or team details appear in the retrieved material.
AI-generated — may contain errors, please verify.
Coverage
Autumn's Prime: Six FreeS Fund Early-Stage Portfolio Companies Raise Nearly 1 Billion RMB | FreeS Family Funding News Vol.15
Looking forward to working alongside more outstanding founders.
AI Medical Device Company "Silicon Based Bionics" Raises Over 800 Million Yuan in Three C-Round Tranches, Led by Source Code Capital
China's first CGM company to receive regulatory approval and achieve mass production without requiring finger-prick calibration
2022, the Door Opens to the Future | 5Y News Monthly
The big news from last month.
5Y News | Vastai Technologies Completes Two Consecutive Rounds of Series B-1 and B-2 Funding, Raising 1.6 Billion RMB
5Y Capital has been closely following the development of China's AI sector.
